These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Integrating the tools for an individualized prognosis in multiple sclerosis. Fernández O J Neurol Sci; 2013 Aug; 331(1-2):10-3. PubMed ID: 23692966 [TBL] [Abstract][Full Text] [Related]
23. Integrating personalized genomic medicine into routine clinical care: addressing the social and policy issues of pharmacogenomic testing. Dressler LG N C Med J; 2013; 74(6):509-13. PubMed ID: 24316779 [TBL] [Abstract][Full Text] [Related]
24. From pharmacogenomics and systems biology to personalized care: a framework of systems and dynamical medicine. Yan Q Methods Mol Biol; 2014; 1175():3-17. PubMed ID: 25150863 [TBL] [Abstract][Full Text] [Related]
25. One size fits one: pharmacogenetics in gastroenterology. Porayette P; Flockhart D; Gupta SK Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737 [TBL] [Abstract][Full Text] [Related]
26. The right roadmap for personalized tests. Bourzac K Cancer Discov; 2012 Jun; 2(6):478. PubMed ID: 22684442 [No Abstract] [Full Text] [Related]
28. The role of genetic information in personalized medicine. Gamma A Perspect Biol Med; 2013; 56(4):485-512. PubMed ID: 24769744 [TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics of methotrexate in pediatric hematological neoplasm treatment: does it need a personalized regimen based on MTHFR polymorphisms? D'Angelo V; Ramaglia M; Iannotta A; Addeo R Expert Rev Hematol; 2014 Oct; 7(5):517-9. PubMed ID: 25213457 [No Abstract] [Full Text] [Related]
30. Genomics and personalized medicine. Sadee W Int J Pharm; 2011 Aug; 415(1-2):2-4. PubMed ID: 21539903 [TBL] [Abstract][Full Text] [Related]
31. Group-based and personalized care in an age of genomic and evidence-based medicine: a reappraisal. Maglo KN Perspect Biol Med; 2012; 55(1):137-54. PubMed ID: 22643722 [TBL] [Abstract][Full Text] [Related]
32. What is clinical utility and why should we care? Lesko LJ; Zineh I; Huang SM Clin Pharmacol Ther; 2010 Dec; 88(6):729-33. PubMed ID: 21081937 [No Abstract] [Full Text] [Related]
33. Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine. Umićević Mirkov M; Coenen MJ Pharmacogenomics; 2013 Mar; 14(4):425-44. PubMed ID: 23438889 [TBL] [Abstract][Full Text] [Related]
34. Asthma pharmacogenetics: responding to the call for a personalized approach. Ortega VE; Wechsler ME Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):399-409. PubMed ID: 23799335 [TBL] [Abstract][Full Text] [Related]
35. Acceptance of biomarker-based tests for application in clinical practice: criteria and obstacles. Pirmohamed M Clin Pharmacol Ther; 2010 Dec; 88(6):862-6. PubMed ID: 20981006 [TBL] [Abstract][Full Text] [Related]